NCT05384106View on ClinicalTrials.gov

AN OPEN-LABEL, ACUTE CLINICAL TRIAL TO ASSESS THE LEVEL OF KETONE PRODUCTION FOLLOWING CONSUMPTION OF AVELA™ (R)-1,3-BUTANEDIOL IN AN ADULT POPULATION

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

(R)-1,3-butanediol

Avela™ (R)-1,3-butanediol is intended to induce ketosis in the general adult population. Avela™ (R)-1,3-butanediol is GRAS for use in beverages, bars, and gels

Trial Locations (1)

92106

Moniker Commons, San Diego

Sponsors

Lead Sponsor

Genomatica Inc.
All Listed Sponsors
lead

Genomatica Inc.

INDUSTRY

NCT05384106 - AN OPEN-LABEL, ACUTE CLINICAL TRIAL TO ASSESS THE LEVEL OF KETONE PRODUCTION FOLLOWING CONSUMPTION OF AVELA™ (R)-1,3-BUTANEDIOL IN AN ADULT POPULATION | Biotech Hunter | Biotech Hunter